Business · 04/04/2016

FDA Clears PRONESTYL Injectable and Other Drug Products for Sale

The US Food and Drug Administration (FDA) has ruled that PRONESTYL (Procainamide Hydrochloride) Injectable and other listed drug products were not withdrawn from sale due to safety or effectiveness concerns, allowing the FDA to continue approving abbreviated new drug applications (ANDAs) for these products.